Quick Answer
Estrella Immunopharma, Inc. reported Shares Outstanding of 36.61 million shares for fiscal year 2024.
Estrella Immunopharma, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 36.61M | +3642.5% |
| 2023 | 978,243 | -31.1% |
| 2022 | 1.42M | +0.0% |
| 2021 | 1.42M | +0.0% |
| 2021 | 1.42M | +0.0% |
| 2021 | 1.42M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| March 31, 2024 | 36.54M | +2473.5% | +3.8% |
| December 31, 2023 | 35.20M | +2379.5% | +0.0% |
| September 30, 2023 | 35.20M | +2379.5% | +3498.4% |
| June 30, 2023 | 978,243 | -31.1% | -31.1% |
| March 31, 2023 | 1.42M | +0.0% | +0.0% |
| December 31, 2022 | 1.42M | +0.0% | +0.0% |
| September 30, 2022 | 1.42M | +0.0% | +0.0% |
| June 30, 2022 | 1.42M | — | +0.0% |
- Estrella Immunopharma, Inc. showed an increase of +3642.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2024 period, Estrella Immunopharma, Inc.’s shares outstanding has grown by 2478.8% (from 1.42 million shares to 36.61 million shares).
- The most recent figure is from Estrella Immunopharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on September 27, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: